APKASS consensus statement on chronic syndesmosis injury

Simple item page
dc.contributor.authorYujie Song
dc.contributor.authorZhongmin Shi
dc.contributor.authorHiroaki Kurokawa
dc.contributor.authorYasuhito Tanaka
dc.contributor.authorSamuel Ka-Kin Ling
dc.contributor.authorPatrick Shu-Hang Yung
dc.contributor.authorChayanin Angthong
dc.contributor.authorSeung Hwan Han
dc.contributor.authorYinghui Hua
dc.contributor.authorHongyun Li
dc.contributor.authorChen Jiao
dc.contributor.authorJianchao Gui
dc.contributor.authorQi Li
dc.date.accessioned2025-07-21T06:05:27Z
dc.date.issued2021-07-01
dc.description.abstractExperts from the Asia-Pacific Knee, Arthroscopy and Sports Medicine Society (APKASS) convened to develop expert-and evidence-based consensus statements in order to assist surgeons and physical therapists in the management of chronic syndesmosis injury.The purpose of this article was to report the results that took place at the 2020 APKASS international consensus meeting on this challenging disorder. MethodsA core group of 13 authors drafted and refined 13 items consisting of 38 clinical questions and statements, which were then assigned to at least 1 of the authors to research and summarize the currently available evidence.Our consensus methodology was designed using a 2-stage Delphi process, which included an online survey (November 20, 2020; stage 1) and an online meeting (December 20, 2020; stage 2).The final document we sent out for stage 1 of the consensus process featured 8 items and 29 statements (available as supplemental material).Each statement was
dc.identifier.doi10.1016/j.asmart.2021.05.008
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/10474
dc.subjectSyndesmosis
dc.subjectStatement (logic)
dc.subjectConsensus conference
dc.subject.classificationInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
dc.titleAPKASS consensus statement on chronic syndesmosis injury
dc.typeReview

Files

Collections

All